Close Menu

New synthetic biology tools may enable genetic engineers to play with metabolic pathways and the genetic code, according to the Economist.

For instance, it reports that Antheia, a firm founded by Christina Smolke, is working on designing new metabolic pathways to cheaply produce opiates for pain relief and to devise ones that are less addictive.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.